These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15860891

  • 1. Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practice.
    Palomares MR, Paz B, Weitzel JN.
    J Clin Oncol; 2005 May 01; 23(13):3165-6; author reply 3166-7. PubMed ID: 15860891
    [No Abstract] [Full Text] [Related]

  • 2. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET, Moyer A, Shannon KM, Niendorf KB, Col NF.
    J Womens Health (Larchmt); 2006 Sep 01; 15(7):843-56. PubMed ID: 16999640
    [Abstract] [Full Text] [Related]

  • 3. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
    Silva E, Lynch H.
    Breast J; 2006 Sep 01; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
    [No Abstract] [Full Text] [Related]

  • 4. Risk estimation for familial breast cancer: improving the system of counselling.
    Gregory H, Wordsworth S, Gibbons B, Wilson B, Haites N.
    Eur J Hum Genet; 2007 Nov 01; 15(11):1139-44. PubMed ID: 17637807
    [Abstract] [Full Text] [Related]

  • 5. Disparities in BRCA testing: when insurance coverage is not a barrier.
    Olaya W, Esquivel P, Wong JH, Morgan JW, Freeberg A, Roy-Chowdhury S, Lum SS.
    Am J Surg; 2009 Oct 01; 198(4):562-5. PubMed ID: 19800469
    [Abstract] [Full Text] [Related]

  • 6. Newly diagnosed breast cancer patients choose bilateral mastectomy over breast-conserving surgery when testing positive for a BRCA1/2 mutation.
    Stolier AJ, Corsetti RL.
    Am Surg; 2005 Dec 01; 71(12):1031-3. PubMed ID: 16447474
    [Abstract] [Full Text] [Related]

  • 7. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A, Bauerfeind I, Untch M, Nestle-Krämling C.
    Psychother Psychosom Med Psychol; 2006 Dec 01; 56(9-10):351-61. PubMed ID: 16804803
    [Abstract] [Full Text] [Related]

  • 8. Breast cancer screening update and evaluation of the high-risk patient.
    Cink TM.
    S D Med; 2010 Dec 01; Spec No():23-30. PubMed ID: 20401983
    [No Abstract] [Full Text] [Related]

  • 9. Hereditary breast-ovarian cancer: clinical findings and medical management.
    Marshall M, Solomon S.
    Plast Surg Nurs; 2007 Dec 01; 27(3):124-7. PubMed ID: 17901820
    [Abstract] [Full Text] [Related]

  • 10. Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
    Roukos DH, Briasoulis E.
    Nat Clin Pract Oncol; 2007 Oct 01; 4(10):578-90. PubMed ID: 17898808
    [Abstract] [Full Text] [Related]

  • 11. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
    Black D, Specht M, Lee JM, Dominguez F, Gadd M, Hughes K, Rafferty E, Smith B.
    Ann Surg Oncol; 2007 Sep 01; 14(9):2477-84. PubMed ID: 17587091
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer disparities and decision-making among U.S. women.
    Polacek GN, Ramos MC, Ferrer RL.
    Patient Educ Couns; 2007 Feb 01; 65(2):158-65. PubMed ID: 16870385
    [Abstract] [Full Text] [Related]

  • 13. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD, Hall MJ.
    Breast J; 2009 Feb 01; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [Abstract] [Full Text] [Related]

  • 14. Targeted tailored management of the breast cancer patient at risk for harboring a germline mutation-current trends affecting the selection of patients considering surgical prophylaxis for breast cancer.
    Silva E.
    Breast J; 2009 Feb 01; 15 Suppl 1():S76-80. PubMed ID: 19775334
    [Abstract] [Full Text] [Related]

  • 15. Recall of and reactions to a surgeon referral letter for BRCA genetic counseling among high-risk breast cancer patients.
    Vadaparampil ST, Quinn GP, Miree CA, Brzosowicz J, Carter B, Laronga C.
    Ann Surg Oncol; 2009 Jul 01; 16(7):1973-81. PubMed ID: 19408048
    [Abstract] [Full Text] [Related]

  • 16. Factors affecting breast cancer risk reduction practices among California physicians.
    Kaplan CP, Haas JS, Pérez-Stable EJ, Des Jarlais G, Gregorich SE.
    Prev Med; 2005 Jul 01; 41(1):7-15. PubMed ID: 15916987
    [Abstract] [Full Text] [Related]

  • 17. Do age and ethnicity predict breast cancer treatment received? A cross-sectional urban population based study. Breast cancer treatment: age and ethnicity.
    Naeim A, Hurria A, Leake B, Maly RC.
    Crit Rev Oncol Hematol; 2006 Sep 01; 59(3):234-42. PubMed ID: 16829122
    [Abstract] [Full Text] [Related]

  • 18. Breast cancer: dreaded diagnosis, complicated care.
    Dest VM, Fisher SM.
    RN; 1994 Jun 01; 57(6):48-54; quiz 55. PubMed ID: 7973391
    [No Abstract] [Full Text] [Related]

  • 19. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ, ten Kroode HF, Ausems MG.
    Patient Educ Couns; 2006 Jul 01; 62(1):13-20. PubMed ID: 16242293
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic mastectomy.
    Zakaria S, Degnim AC.
    Surg Clin North Am; 2007 Apr 01; 87(2):317-31, viii. PubMed ID: 17498529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.